Loading patent…
AssigneeUEA Enterprises Limited
InventorsColin Stephen Cooper, Daniel Simon Brewer, Rachel Hurst, Abraham Farag Salah Gihawi, Justin Joseph O'Grady, John Richard Wain, Emma Jane Meader, Ghanasyam Rallapalli
Estimating the term…
The present invention relates to prostate cancer (PC), in particular the identification of certain bacteria in prostate cancer tissues or liquid biopsies and the use of such identification as a prognostic indicator of cancer progression. The present invention also relates to cultures of newly identified bacteria and means for identifying such bacteria in biological samples.
A method of providing a cancer prognosis in a patient based on the presence of one or more bacteria in a biological sample from the patient, comprising:
A method of detecting the presence of one or more bacteria selected from the genera Fenollaria, Peptoniphilus, Porphyromonas, Anaerococcus and Fusobacterium in a biological sample from the patient.
The method according to any preceding claim wherein the sample is from a human.
A cell culture comprising bacteria Varibaculum prostatecancerukia identified by ECACC deposit number 21092203 or DSMZ accession number DSM 34057.
A cell culture comprising bacteria Fenollaria sporofastidiosus identified by ECACC deposit number 21092201 or DSMZ accession number DSM 34056.
A cell culture comprising bacteria Peptoniphilus rachelemmaiella identified by ECACC deposit number 21092202 or DSMZ accession number DSM 34055.
A cell culture comprising bacteria Porphyromonas bobii identified by ECACC deposit number 21092204 or DSMZ accession number DSM 34063.
Dependencies are inferred from the claim text.